8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
PFIZER INC filed an 8‑K on Feb 3, 2026 attaching a press release (Exhibit 99) reporting Pfizer’s Q4 2025…
Filed with the SEC on · Summarized by InvestorsBot
PFIZER INC filed an 8‑K on Feb 3, 2026 attaching a press release (Exhibit 99) reporting Pfizer’s Q4 2025 financial results — see the release for revenues, EPS and guidance details. $PFE 📢 #Pfizer #earnings
The 8‑K also includes an Inline XBRL cover page (Exhibit 104). Filing signed Feb 3, 2026 by Margaret M. Madden, SVP & Corporate Secretary. Review XBRL for machine‑readable financial detail. $PFE 💾 #XBRL #8K